Anil Kapur

Mr. Kapur is a deeply experienced executive with over 25 years of experience in pharmaceutical and biotech companies across both US and international markets. He has held senior leadership positions where he has been responsible for the launches of significant global brands, building, and managing commercial capabilities in both small and large organizations, driving corporate strategy and managing alliances. He is currently the Executive Vice President, Corporate Strategy and Chief Commercial Officer at Geron Corporation. Prior to Geron, Mr. Kapur served as the Chief Commercial Officer at Actinium Pharmaceuticals, Inc. and as the Vice President, Head of Early Assets, Biomarkers and External Innovation for Worldwide Oncology Commercialization at Bristol-Myers Squibb Company. Previously, Mr. Kapur was Vice President, Global Head of Commercial and Portfolio Strategy at Baxalta, Incorporated, which was acquired by Shire PLC in 2016. Before joining Baxalta, Mr. Kapur served as the Vice President, Commercial Leader Hematology Franchise at Johnson & Johnson’s global pharmaceutical strategy organization and in various sales and marketing leadership roles. Mr. Kapur holds a BE from Birla Institute of Technology in India, an MS in Industrial Engineering from Louisiana Tech University, and an MBA from the Fuqua School of Business at Duke University.